Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N‑[(1S)‑2-amino‑1‑phenylethyl]‑5‑(1H-pyrrolo[2,3-b]pyridin‑4‑yl)thiophene‐2‑carboxamide is a synthetic small molecule with the molecular formula C20H18N4OS and a molecular weight of approximately 362.45 g/mol. It is catalogued as an experimental compound in chemical and pharmacological databases but does not have any approved medical indications or known clinical development programs. The compound has been referenced in research contexts as a potential bioactive molecule; however, its precise mechanism of action and biological targets are not established in public sources. No information on its pharmacodynamics or therapeutic applications is available at this time[6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide.